Under two weeks until #AIMBE2025! This is a critical time for advocacy, and no event unites leaders in medical and biological engineering like this. We're excited to welcome new AIMBE Fellows, who will also join key advocacy efforts to advance biomedical innovation. annualevent.aimbe.org

Thank you to all the sponsors and exhibitors of our #AIMBE2025 Annual Event on March 29-31! We look forward to seeing all our meeting participants here in DC in less than three weeks @fiu.bsky.social @uconn.bsky.social

AIMBE is thrilled to announce that Congressman Bill Foster @repbillfoster.bsky.social, Co-Chair of the Congressional R&D Caucus and the only PhD physicist in Congress, will kick-off this year’s AIMBE Annual Event program on Monday morning! Register here: annualevent.aimbe.org.

Take action now. NIH’s 15% indirect cost cap threatens research institutions, jobs, and innovation. Customize & send AIMBE’s advocacy letter to urge Congress to stop this harmful policy. Your voice matters!

American Institute for Medical & Biological Engineering (AIMBE)@aimbe-official.bsky.social · 2y ago

AIMBE has developed a new advocacy letter on the changes to NIH indirect cost rates: aimbe.org/advocate/wri... We urge the broader biomedical research community to customize this letter (<1 minute) to contact your congressional representatives about the severe consequences of this new policy 👇

It was great to connect with this group. Science advocacy is more important now than ever!

Kristy Ainslie's Lab@kristy-ainslie-lab.bsky.social · 2y ago

@julienguyenlab.bsky.social & I organized leaders from Pharmacy Schools to discuss AI in grad ed, financial support challenges & science advocacy w/ @dawnberaud.bsky.social. Also a NextProf PharmSci program. Many of these discussions are relevant to all grad ed. Open Access: rdcu.be/d8D7A

Funding delays and policy changes are disrupting labs, jeopardizing jobs, and putting the future of science and biomedical engineering at risk. Trainees and early-career researchers are being hit hardest. @aimbe-official.bsky.social is taking action. Read our statement & send a letter to Congress

American Institute for Medical & Biological Engineering (AIMBE)@aimbe-official.bsky.social · 2y ago

AIMBE has posted a public statement on the impact of federal policy changes on biomedical research: aimbe.org/advocate/wri... Above, we have also developed an advocacy letter for members of the medical & biological engineering community to send to their congressional representatives on this matter.

Reps. Jamie Raskin, Chris Van Hollen, & Angela Alsobrooks call on HHS to immediately restore NIH operations amid research disruptions caused by new restrictions. "The consequences of further delays could be disastrous for medical progress." Read more: raskin.house.gov/2025/1/raski...

Raskin, Van Hollen, Alsobrooks Sound Alarm on NIH Disruptions, Urge Immediate Restoration of Operations

raskin.house.gov

NIAID researcher, Matthew Memoli, named Acting NIH Director. www.niaid.nih.gov/research/mat...

Matthew J. Memoli, M.D., M.S.

Matthew J. Memoli, M.D., M.S. is the Director of the Laboratory of Infectious Diseases (LID) Clinical Studies Unit (CSU). The LID CSU seeks to perform translational research studies to answer fundamen...

niaid.nih.gov

Excited to see everyone at #AIMBE2025! With a new Congress and administration, this is a critical time for researchers to engage in science policy. Your voices need to be heard. Don’t miss it—register now: annualevent.aimbe.org

American Institute for Medical & Biological Engineering (AIMBE)@aimbe-official.bsky.social · 2y ago

AIMBE's Annual Event on March 29-31, 2025 is especially important. With a new Congress and presidential administration, it's a timely opportunity to engage in science policy post-election. Fellows, register now and we will arrange your congressional visits for you: annualevent.aimbe.org #AIMBE2025